The forecasted sales of Genito Urinary System and Sex Hormones in Sweden indicate a slight downward trend from 2023 to 2028. Starting from 3.0% of total sales in 2024, the value is expected to gradually decrease to 2.7% by 2028. The year-on-year variations are marginal, with a -3.33% change from 2024 to 2025 and a consistent -3.45% annual decrease until 2028. The compounded annual growth rate (CAGR) over this period suggests a stable, yet slow, decline over the years.
Future trends to watch for include potential advancements in related medical treatments, changes in healthcare policies, and evolving population demographics, which could influence both demand and sales dynamics in this sector.
